Skip to main content

Table 4 Available patient data on response to drug treatment

From: Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity

Patient

Primary

culture

1st line therapy

1st line response

(3 cycle)

1st line response

(6 cycle)

2nd line therapy

2nd line response

(3 cycle)

#1

PE g/11

Cis + Vin

PR

SD

Erlotinib

PD

#2

PE n/11

Cis + Vin

PD

   

#3

PE p/11

Cis + Gem

SD

SD

Pemetrexed

PD

#4

PE r/11

Cis + Gem + Beva

PR

   

#5

PE s/11

Cis + Taxotere

PR

   

#6

PE u/11

Cis + Gem + Beva

PR

   
  1. Clinical response: PD progression disease, SD stable disease, PR partial regression, CR complete